Acrylamide Exposure and Glycemic Dysregulation: A Population-Based Study.

INTRODUCTION Acrylamide has been shown to induce oxidative stress and β-cell toxicity in animal studies; however, population-based evidence remains limited and inconsistent. Therefore, this study aimed to evaluate the associations between acrylamide (AA) hemoglobin biomarkers and the risk of prediabetes and diabetes in the US population.

Methods

Data were obtained from the 2013-2016 National Health and Nutrition Examination Survey (NHANES). Participants were classified into diabetes, prediabetes, and healthy control groups by their glycometabolic status. The associations between prediabetes and diabetes with AA biomarkers, specifically hemoglobin adducts of acrylamide (HbAA), glycidamide (HbGA), the Hb- GA/HbAA ratio, and their combined levels (HbAA + HbGA), were investigated using multivariate logistic regression and restricted cubic spline models.

Results

The fully adjusted logistic regression analyses indicated that participants in the highest HbGA quartile had a significantly elevated risk of prediabetes (odd ratio [OR] = 2.47, 95% confidence interval [CI]: 1.52-4.02, P = 0.007; Ptrend = 0.005) and diabetes (OR = 2.46, 95% CI: 1.27-4.73, P = 0.019; Ptrend = 0.043). The HbGA/HbAA ratio showed a positive correlation with prediabetes (OR = 2.10, 95% CI: 1.05-4.20, P = 0.042; Ptrend = 0.024) and diabetes (OR = 5.58, 95% CI: 2.10-14.79, P = 0.008; Ptrend < 0.001). In contrast, HbAA levels were not significantly associated with either prediabetes (OR = 1.49, 95% CI: 0.86-2.61, P = 0.116; Ptrend = 0.088) or diabetes (OR = 0.92, 95% CI: 0.47-1.81, P = 0.744; Ptrend = 0.351).

Discussion

The divergent patterns observed for HbAA and the HbGA/HbAA ratio may reflect a shift from exogenous exposure to intrinsic metabolic capacity across different stages of disease progression.

Conclusion

Higher HbGA levels and elevated HbGA/HbAA ratios were associated with an increased prevalence of prediabetes and diabetes. Further research is needed to clarify the causal role of acrylamide exposure in abnormal glucose metabolism.